Co-Authors
This is a "connection" page, showing publications co-authored by KAMRAN AHRAR and JOSE ANTONIO KARAM.
Connection Strength
1.541
-
Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experience. Eur Radiol. 2024 Feb 24.
Score: 0.247
-
Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy. Eur Urol Open Sci. 2023 Nov; 57:45-50.
Score: 0.241
-
Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience. Cancers (Basel). 2023 Jan 31; 15(3).
Score: 0.230
-
Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies. AJR Am J Roentgenol. 2021 07; 217(1):157-163.
Score: 0.203
-
Salvage surgery after energy ablation for renal masses. BJU Int. 2015 Jan; 115(1):74-80.
Score: 0.131
-
Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma. Eur Urol. 2014 Nov; 66(5):874-80.
Score: 0.123
-
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results. BJU Int. 2013 May; 111(6):997-1005.
Score: 0.116
-
Ablation of kidney tumors. Surg Oncol Clin N Am. 2011 Apr; 20(2):341-53, viii.
Score: 0.099
-
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol. 2010 Nov; 184(5):1882-7.
Score: 0.097
-
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma. Nat Commun. 2021 11 04; 12(1):6375.
Score: 0.053